医学
医疗保健
梅德林
急诊科
疾病
肾脏疾病
糖尿病
数据提取
慢性病
家庭医学
重症监护医学
病理
护理部
内科学
内分泌学
政治学
法学
经济
经济增长
作者
Nancy D Berkman,Eva Chang,Julie Seibert,Rania Ali
摘要
Accurately identifying high-need, high-cost (HNHC) patients to reduce their preventable or modifiable health care use for their chronic conditions is a priority and a challenge for U.S. policymakers, health care delivery systems, and payers.To identify characteristics and criteria to distinguish HNHC patients.Searches of multiple databases and gray literature from 1 January 2000 to 22 January 2022.English-language studies of characteristics and criteria to identify HNHC adult patients, defined as those with high use (emergency department, inpatient, or total services) or high cost.Independent, dual-review extraction and quality assessment.The review included 64 studies comprising multivariate exposure studies (n = 47), cluster analyses (n = 11), and qualitative studies (n = 6). A National Academy of Medicine (NAM) taxonomy was an initial "best-fit" framework for organizing the synthesis of the findings. Patient characteristics associated with being HNHC included number and severity of comorbid conditions and having chronic clinical conditions, particularly heart disease, chronic kidney disease, chronic lung disease, diabetes, cancer, and hypertension. Patients' risk for being HNHC was often amplified by behavioral health conditions and social risk factors. The reviewers revised the NAM taxonomy to create a final framework, adding chronic pain and prior patterns of high health care use as characteristics associated with an increased risk for being HNHC.Little evidence distinguished potentially preventable or modifiable health care use from overall use.A combination of characteristics can be useful for identifying HNHC patients. Because of the complexity of their conditions and circumstances, improving their quality of care will likely also require an individualized assessment of care needs and availability of support services.Agency for Healthcare Research and Quality. (PROSPERO: CRD42020161179).
科研通智能强力驱动
Strongly Powered by AbleSci AI